ARCHIVES

Fisher and Redmond Subject Of Misconduct Investigation; ORI

This article is from The Cancer Letter archive.

Vol. 20 No. 18 | May 6, 1994

Download PDF Visit The Full Archive

Related Articles

Six Institutions Get Awards For LAK-IL-2 Trials

February 7, 1986

NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG

November 3, 1978

In Brief: Robert Bast Succeeds Singleton As Director Of Duke Cancer Center; Robert Bell Deputy

August 14, 1987

GAO Report To Include Some But Not all Of Obey’s Charges

June 24, 1977

NIH To Site Visit Animal Facilities

March 18, 1983

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

March 8, 2002